SEFA-6179 / NorthSea Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SEFA-6179 / NorthSea Therap
NCT05919680: A Study of NST-6179 in Adult Subjects With Intestinal Failure-Associated Liver Disease (IFALD).

Recruiting
2
36
US
NST-6179 Part A, NST-6179 Part B, Matched Placebo
NorthSea Therapeutics B.V.
Intestinal Failure Associated Liver Disease
06/25
06/25

Download Options